Paragon 28, Inc. (NYSE:FNA – Get Free Report) shares were up 5.2% during trading on Tuesday . The company traded as high as $10.63 and last traded at $10.52. Approximately 317,424 shares were traded during trading, a decline of 48% from the average daily volume of 607,096 shares. The stock had previously closed at $10.00.
Analyst Upgrades and Downgrades
FNA has been the topic of a number of recent research reports. Canaccord Genuity Group decreased their target price on Paragon 28 from $17.00 to $15.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Needham & Company LLC raised their price objective on Paragon 28 from $11.00 to $13.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Finally, Stephens upgraded Paragon 28 to a “strong-buy” rating in a research report on Monday, December 2nd. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Paragon 28 has an average rating of “Buy” and an average target price of $15.60.
Read Our Latest Report on Paragon 28
Paragon 28 Stock Performance
Paragon 28 (NYSE:FNA – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.01. The company had revenue of $62.30 million for the quarter, compared to analyst estimates of $60.58 million. Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. The company’s revenue was up 18.0% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.10) EPS. As a group, equities analysts predict that Paragon 28, Inc. will post -0.66 EPS for the current year.
Insiders Place Their Bets
In related news, major shareholder Mvm Partners, Llc sold 72,133 shares of the firm’s stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $10.16, for a total transaction of $732,871.28. Following the completion of the sale, the insider now directly owns 10,559,065 shares of the company’s stock, valued at $107,280,100.40. This trade represents a 0.68 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders sold 252,914 shares of company stock worth $2,585,514 over the last three months. 15.32% of the stock is currently owned by corporate insiders.
Institutional Trading of Paragon 28
Large investors have recently made changes to their positions in the business. Barclays PLC increased its holdings in shares of Paragon 28 by 180.6% in the third quarter. Barclays PLC now owns 84,812 shares of the company’s stock valued at $567,000 after purchasing an additional 54,591 shares in the last quarter. Geode Capital Management LLC boosted its position in Paragon 28 by 2.5% in the 3rd quarter. Geode Capital Management LLC now owns 967,519 shares of the company’s stock valued at $6,464,000 after buying an additional 23,167 shares during the last quarter. Wellington Management Group LLP increased its stake in shares of Paragon 28 by 7.0% in the 3rd quarter. Wellington Management Group LLP now owns 694,799 shares of the company’s stock valued at $4,641,000 after buying an additional 45,215 shares during the period. State Street Corp raised its position in shares of Paragon 28 by 2.6% during the third quarter. State Street Corp now owns 1,563,331 shares of the company’s stock worth $10,443,000 after acquiring an additional 39,075 shares during the last quarter. Finally, Stonepine Capital Management LLC acquired a new position in shares of Paragon 28 during the third quarter valued at $766,000. Institutional investors own 63.57% of the company’s stock.
Paragon 28 Company Profile
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
See Also
- Five stocks we like better than Paragon 28
- What is an Earnings Surprise?
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- How to Use Stock Screeners to Find Stocks
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Buy P&G Now, Before It Sets A New All-Time High
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.